Wondr Health

The Wondr Health team is attending Becker's Healthcare’s Fall Payer Issues Roundtable next week in Chicago! Connect with Margot Case on-site to learn how Wondr Health can help your populations thrive and control costs – at the same time.    #BeckersPayer 

Halloween is over, but the holiday festivities (and treats!) are ramping up. How do Wondr participants keep their cool and their health goals throughout the holiday frenzy? Don’t miss next week’s participant webinar "Sleigh the holidays". Get a sneak peek at Wondr holiday strategies with our instructor and clinical psychologist, Dana Broussard Labat, M.A., Ph.D. From navigating parties to healthy eating strategies and managing very real seasonal stressors, Dr. Labat shares tips and tricks for you or your people to not just survive but THRIVE this season. Sign up at https://lnkd.in/gWWzjCju to learn:  🌟 How to spot common holiday-season weight loss barriers  🌟 An entire toolbox of strategies that set our participants up for success  🌟 A recipe for a nutritious and delicious seasonal treat - straight out of the Wondr Kitchen  🌟 And more! 

A very happy and healthy Halloween from Wondr Health! We had a fantastic time celebrating in-person and remotely - check out some of our costumes including a few Wondr pets 🎃

Our recent experience at the #HLTH2024 event inspired us with the excitement surrounding advancements in health care but also highlighted the spread of misinformation about obesity medicine and GLP-1s. At Wondr Health, we are dedicated to sharing evidence-based insights that prioritize the well-being of our participants and partners. In our latest blog, we clarify myths surrounding obesity care and challenge bias around weight.  

Exciting news! We're pleased to share that Wondr Health has joined The Partner Collective™ by CollectiveHealth, improving access to full-spectrum weight and obesity care for all populations. As a member of The Partner Collective, we've joined a digital health partner hub that makes it easy for benefits leaders and consultants to evaluate and compare a broad range of digital health solutions in one place. Born in the benefits space 17 years ago, Wondr is an integrated, modular solution that starts with expert, proven behavioral support and offers medication management and personalized clinical support for people on weight-loss drugs. Distinguished by its ability to scale and flex, Wondr helps organizations engage their workforce, improve clinical outcomes, and lower healthcare costs. Learn more about Wondr, visit The Partner Collective at https://lnkd.in/gvAecuMY

Halloween is just around the corner – with parties, costumes, and CANDY. When surrounded by so many tempting treats, sticking to health goals can be tricky. Wondr coach Cami shares a few simple strategies our participants use to navigate the holiday without derailing progress. See how we help our participants carve out a fun (and healthy!) Halloween. 🎃 

Our team was inspired by our time at #HLTH2024 and energized by the enthusiasm for our space, but with that also came the proliferation of misinformation specific to obesity medicine and GLP-1s. It is our job as leaders to hold each other accountable and dispel any false claims. At Wondr Health, we are committed to providing information that is backed by science and in the best interest of our participants and partners. With that, we would like to tackle a few misconceptions heard at HLTH and shine a light on bias when it comes to obesity medicine. MISCONCEPTION 1: Drug holidays can be beneficial for GLP-1s.  There was a lot of chatter about GLP-1 “drug holidays” - when someone intentionally stops taking their medication for a period of time. Common reasons for these treatment breaks include decreasing side effects, reducing tolerance, or to evaluating progress and determining the next course of treatment – NOT cost containment. A strong word of caution when considering “drug holidays” - obesity is a chronic condition similar to hypertension and diabetes. You wouldn’t take a drug holiday from your hypertension or diabetes medicine, would you? Why would it be any different with weight loss? Medication breaks aren’t something to be taken lightly – one study found that semaglutide recipients regained two-thirds of their lost weight within 12 months of stopping treatment. Curious about other misconceptions we saw? Stay tuned for our upcoming blog next week, where we will address more misconceptions and discuss practical, sustainable care solutions or take a look at our Chief Growth Officer, Margot Case’s HLTH insights here: https://lnkd.in/geKMJ9u9  

What makes the latest GLP-1 research the “gift that keeps on giving”? This study found that GLP-1s can address obesity and cardiovascular health for an extremely diverse population over a long period of time. This adds to the mounting research of the impact of GLP-1s on many chronic conditions that drive up employer health-care costs. To learn more, join our on-demand webinar, “Clinical Conversation: Broader Impact of GLP-1s,” where Dr. Donna Ryan and Tim Church, MD, MPH, PhD discuss findings from a large, diverse population study that goes beyond weight management – and the impact on treatment for cardiovascular disease, kidney health, and more. 

The Wondr Health team is heading to sunny Miami for the ACP Productions ACO/Payers Innovation Fusion on October 27th. Make sure to connect with Deborah O'Connor and Margot Case on-site to learn how Wondr Health can help your populations thrive and control costs – at the same time. 

Our Chief Medical Officer, Tim Church, MD, MPH, PhD, joined Health Tech Talk Show hosts, Kat McDavitt and Lisa, the #HLTHUSA 2024 conference - skip to 48:50 to see their discussion about what employers need to know about GLP-1s 📣